sumi.news
Search
Following
Sign in
← Back to news
S
Seeking Alpha: News
RSS Feed
seekingalpha.com/market-news
seekingalpha.com/market_currents.xml
Follow
Latest
Wed Apr 8
Pembina Pipeline raises dividend by 3.5% to C$0.735
1d
S
PTC outlines 2026 product revenue guidance of $750M-$850M driven by Sephience launch momentum
1d
S
Afya GAAP EPS of R$2.85, revenue of R$1.01B; reaffirms FY26 outlook
1d
S
Gogo reiterates 2026 revenue of $905M-$945M as it targets LTE network completion by end of 2026
1d
S
Myomo outlines $10.3M-$10.8M Q2 revenue while reiterating $43M-$46M for 2026
1d
S
Atrium Mortgage Investment Corporation declares $0.0775 dividend
1d
S
WELL Health Technologies beats top-line estimates; reaffirms FY26 outlook
1d
S
Baytex Energy Corp. declares CAD 0.0225 dividend
1d
B
Wheaton Precious Metals declares $0.195 dividend
1d
B
South Bow Corporation declares $0.50 dividend
1d
B
National Healthcare raises dividend by 4.7% to $0.67 dividend
1d
B
Murphy USA raises dividend by 1.6% to $0.64
1d
B
Sony GAAP EPS of ¥171.44, revenue of ¥12479.62B; gives FY27 outlook
1d
B
M-tron Industries GAAP EPS of $0.67 beats by $0.08, revenue of $14.69M beats by $0.31M
1d
S
Cresud GAAP EPS of ARS 189.99
1d
S
Materion raises dividend by 3.6% to $0.145
1d
S
FTAI Infrastructure declares $0.03 dividend
1d
S
Morgan Stanley Direct Lending Fund declares $0.45 dividend
1d
S
Drilling Tools International misses top-line and bottom-line estimates; reaffirms FY26 outlook
1d
S
Trump reportedly plans smaller CEO delegation for Beijing summit
1d
S
Concentra Group Holdings Parent declares $0.0625 dividend
1d
S
Palvella targets 2H 2026 NDA filing while outlining >$1B peak U.S. sales potential for QTORIN rapamycin in microcystic lymphatic malformations
1d
S
Arcturus outlines 12-week ARCT-032 Phase II enrollment and extends cash runway beyond Q2 2028
1d
S
NBH Holdings declares $0.32 dividend
1d
S
Paul Mueller declares $0.30 dividend
1d
S
Molson Coors declares $0.48 dividend
1d
S
Kodiak Gas Services declares $0.49 dividend
1d
S
LTC targets $600M SHOP acquisitions as SHOP mix is projected at 45% of investments and 40% of NOI by year-end
1d
S
El Pollo Loco projects 2026 adjusted EBITDA of $67.5M-$69.5M while targeting 2%-4% comp growth
1d
S
N-able outlines $167M-$171M 2026 adjusted EBITDA with focus on AI-led automation and back-half ARR ramp
1d
S
Clarus forecasts 2026 sales of $245M-$255M and adjusted EBITDA of $3M-$5M as it launches strategic alternatives review
1d
S
Coinbase impacted as Amazon Web Services works to restore overheated Virginia data center
1d
S
BKV targets 1.4 GW of incremental power generation while outlining $280M-$340M of 2026 power growth capital
1d
S
Friday’s Economic Calendar
1d
S
Akamai anticipates double-digit annual revenue growth in 2027, driven by a 7-year $1.8B CIS commitment
1d
S
Ormat outlines $1.11B-$1.16B 2026 revenue guidance while advancing 2-4 MW EGS pilots for 2027
1d
S
Maximus forecasts $8.25-$8.55 FY 2026 adjusted EPS while raising near-term adjusted EBITDA margin target to 12%-15%
1d
S
Proficient Auto Logistics forecasts Q2 2026 revenue of $105M-$110M as capacity tightening reshapes auto haul pricing
1d
S
First Advantage reaffirms 2026 outlook while expecting adjusted EBITDA margins around 29% in 2H
1d
S
Verastem outlines cash runway into the first half of 2027 while targeting LGSOC self-sustainability in the second half of 2026
1d
S
Nuveen Churchill outlines $0.38 per share Q2 distribution as spreads move toward 5%–5.25%
1d
S
Monster signals modest sequential cost increases through end of 2026 as SAP S/4HANA go-live targets Jan. 1, 2028
1d
S
Ginkgo outlines $125M-$150M 2026 cash burn guidance while expanding Nebula to 103 racks
1d
S
Vericel forecasts $326M-$336M 2026 revenue as BARDA-backed NexoBrid procurement begins in H2
1d
S
NuScale anticipates TVA PPA later this year while advancing 6 GW ENTRA1 program
1d
S
Diodes expects Q2 revenue of about $435M and non-GAAP EPS of $0.60, driven by automotive, industrial and AI server demand
1d
S
Delcath outlines at least $100M 2026 revenue as it targets 37 active centers by year-end
1d
S
Profound outlines ~$25M 2026 revenue, anticipates FDA clearance for Siemens Free integration by year-end
1d
S
OmniAb forecasts $28M-$33M 2026 revenue as partner milestones lift outlook
1d
S
More →